CD34 and acute promyelocytic leukemia: To characterize the APL-specific epigenetic landscape, 5 APL patients, 9 normal karyotype non-APL AML (from now on referred to as AML in the manuscript) patients, and CD34 + bone marrow samples from 5 healthy donors were analyzed.